AR229951A1 - Procedimiento para la elaboracion de derivados del alcohol 1-alfa-(n-carbamoil-hidroxi-fenoxi)-alquilen-aminometil-arilico - Google Patents

Procedimiento para la elaboracion de derivados del alcohol 1-alfa-(n-carbamoil-hidroxi-fenoxi)-alquilen-aminometil-arilico

Info

Publication number
AR229951A1
AR229951A1 AR283669A AR28366980A AR229951A1 AR 229951 A1 AR229951 A1 AR 229951A1 AR 283669 A AR283669 A AR 283669A AR 28366980 A AR28366980 A AR 28366980A AR 229951 A1 AR229951 A1 AR 229951A1
Authority
AR
Argentina
Prior art keywords
arilico
alquilen
aminometil
fenoxi
carbamoil
Prior art date
Application number
AR283669A
Other languages
English (en)
Spanish (es)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of AR229951A1 publication Critical patent/AR229951A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
AR283669A 1978-06-05 1980-12-17 Procedimiento para la elaboracion de derivados del alcohol 1-alfa-(n-carbamoil-hidroxi-fenoxi)-alquilen-aminometil-arilico AR229951A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH613678 1978-06-05

Publications (1)

Publication Number Publication Date
AR229951A1 true AR229951A1 (es) 1984-01-31

Family

ID=4304840

Family Applications (3)

Application Number Title Priority Date Filing Date
AR283669A AR229951A1 (es) 1978-06-05 1980-12-17 Procedimiento para la elaboracion de derivados del alcohol 1-alfa-(n-carbamoil-hidroxi-fenoxi)-alquilen-aminometil-arilico
AR283668A AR229022A1 (es) 1978-06-05 1980-12-17 Procedimiento para la elaboracion de derivados del alcohol 1-alfa-(n-(carbamoil-hidroxi-fenoxi)-alquilenaminometil-arilico
AR283670A AR229581A1 (es) 1978-06-05 1980-12-17 Procedimiento para la elaboracion de derivados del alcohol 1-alpha-(n-carbamoil-hidroxi-fenoxi)-alquilen-aminometil-arilico

Family Applications After (2)

Application Number Title Priority Date Filing Date
AR283668A AR229022A1 (es) 1978-06-05 1980-12-17 Procedimiento para la elaboracion de derivados del alcohol 1-alfa-(n-(carbamoil-hidroxi-fenoxi)-alquilenaminometil-arilico
AR283670A AR229581A1 (es) 1978-06-05 1980-12-17 Procedimiento para la elaboracion de derivados del alcohol 1-alpha-(n-carbamoil-hidroxi-fenoxi)-alquilen-aminometil-arilico

Country Status (26)

Country Link
US (1) US4460580A (fr)
EP (1) EP0005848B1 (fr)
JP (1) JPS54163543A (fr)
KR (4) KR840000926B1 (fr)
AR (3) AR229951A1 (fr)
AT (1) ATE511T1 (fr)
AU (1) AU522483B2 (fr)
CA (1) CA1124241A (fr)
CY (1) CY1256A (fr)
DD (1) DD144050A5 (fr)
DE (1) DE2961669D1 (fr)
DK (1) DK229879A (fr)
ES (1) ES481238A1 (fr)
FI (1) FI791727A (fr)
GB (1) GB2026474B (fr)
GR (1) GR74057B (fr)
HK (1) HK15585A (fr)
HU (1) HU182019B (fr)
IL (1) IL57471A (fr)
MY (1) MY8500690A (fr)
NO (1) NO149034C (fr)
NZ (1) NZ190632A (fr)
PL (5) PL116597B1 (fr)
PT (1) PT69723A (fr)
SG (1) SG45884G (fr)
ZA (1) ZA792748B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006735B1 (fr) * 1978-06-28 1983-06-15 Beecham Group Plc Amines secondaires, procédé pour leur préparation, compositions pharmaceutiques les contenant et leur utilisation
AU538622B2 (en) * 1979-06-29 1984-08-23 Glaxo Group Limited 5-substituted thiophene carboxamides
DD202692A5 (de) * 1979-12-04 1983-09-28 Ciba Geigy Verfahren zur herstellung neuer derivate des 2-amino-aethanols
JPS5726653A (en) * 1980-05-09 1982-02-12 Ciba Geigy Ag Substituted phenyl ether
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
GR74992B (fr) * 1980-08-13 1984-07-12 Ciba Geigy Ag
JPS57185243A (en) * 1981-05-08 1982-11-15 Ciba Geigy Ag Substituted 2-aminoethanol
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
FR2543139B1 (fr) * 1983-03-22 1985-08-16 Cerm Cent Europ Rech Mauvernay Derives de (1-alcoxy 2-amino) ethyl pyridine ou pyrazine, leur preparation et leur application en therapeutique
DE3621775A1 (de) * 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3608290A1 (de) * 1986-03-13 1987-09-24 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA1287061C (fr) * 1986-06-27 1991-07-30 Roche Holding Ltd. Derives de pyridineethanolamines
GB8714901D0 (en) * 1986-07-23 1987-07-29 Ici Plc Amide derivatives
DE3627663A1 (de) * 1986-08-14 1988-03-03 Bayer Ag Heteroarylethylamine, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer bei tieren
US5108363A (en) * 1988-02-19 1992-04-28 Gensia Pharmaceuticals, Inc. Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds
JPH0466934A (ja) * 1990-07-04 1992-03-03 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US5232948A (en) * 1990-09-10 1993-08-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
MX9204881A (es) * 1991-08-23 1993-04-01 Nps Pharma Inc Composicion farmaceutica que comprende moleculas activas, receptoras de calcio.
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5208252A (en) * 1992-07-24 1993-05-04 Ortho Pharmaceutical Corporation Aminoethylthiophene derivatives
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
WO1995019336A1 (fr) * 1994-01-12 1995-07-20 Iovis Biomedical And Pharmaceutical Consultants Ethers de phenylethanolamine et leur utilisation comme agonistes des recepteurs adrenergiques beta
DK1203761T3 (da) 1994-12-08 2005-04-11 Nps Pharma Inc Calciumreceptoraktive forbindelser
JP4117506B2 (ja) 1996-05-01 2008-07-16 エヌピーエス ファーマシューティカルズ インコーポレイテッド 無機イオン活性化合物
KR100380520B1 (ko) * 2000-09-08 2003-04-23 한국화학연구원 피리딘을 포함한 β-아미노알코올 유도체
JP2005523565A (ja) * 2002-04-22 2005-08-04 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 発光スクリーン
US7538141B2 (en) * 2004-03-23 2009-05-26 Alan Daniel Brown Compounds for the treatment of diseases
EP2544677A4 (fr) * 2010-03-08 2013-07-10 Univ Tennessee Res Foundation Agonistes du récepteur bêta-adrénergique et leurs utilisations
ITMI20122221A1 (it) * 2012-12-21 2014-06-22 C4T S C A R L Nuovi composti del 2,3-diidro-4h-1,3-benzossazin-4-one, metodo per prepararli e forma farmaceutica che li comprende
CN104008939B (zh) * 2014-06-19 2016-05-11 苏州普京真空技术有限公司 一种耐用电子枪灯丝
USD954933S1 (en) 2018-06-01 2022-06-14 Chiaro Technology Limited Breast pump accessory

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1178400A (en) * 1966-12-13 1970-01-21 Delalande Sa Nitrogen Substituted Amines and their process of Preparation.
DE1543538A1 (de) * 1966-12-30 1976-02-05 Degussa Verfahren zur herstellung neuer heterocyclischer aminoalkohole
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
GB1398738A (en) * 1972-12-05 1975-06-25 Pfizer Ltd Propanolamine derivatives
US4082772A (en) * 1975-04-18 1978-04-04 American Home Products Corporation Thiophene ethanolamines
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines

Also Published As

Publication number Publication date
PL116529B1 (en) 1981-06-30
EP0005848B1 (fr) 1981-12-30
HK15585A (en) 1985-03-15
PL117155B1 (en) 1981-07-31
IL57471A (en) 1982-11-30
PL116612B1 (en) 1981-06-30
NO149034C (no) 1984-02-01
CA1124241A (fr) 1982-05-25
ZA792748B (en) 1980-06-25
DE2961669D1 (en) 1982-02-18
SG45884G (en) 1985-03-08
DD144050A5 (de) 1980-09-24
JPS54163543A (en) 1979-12-26
KR840000926B1 (ko) 1984-06-29
AU522483B2 (en) 1982-06-10
AR229022A1 (es) 1983-05-31
MY8500690A (en) 1985-12-31
US4460580A (en) 1984-07-17
GB2026474A (en) 1980-02-06
PL216090A1 (fr) 1980-03-24
CY1256A (en) 1984-11-23
AR229581A1 (es) 1983-09-30
PT69723A (de) 1979-07-01
GB2026474B (en) 1982-07-14
AU4773679A (en) 1979-12-13
ES481238A1 (es) 1980-02-16
KR830000681A (ko) 1983-04-18
PL117158B1 (en) 1981-07-31
KR830000680A (ko) 1983-04-18
NZ190632A (en) 1984-07-06
HU182019B (en) 1983-12-28
DK229879A (da) 1979-12-06
KR830000679A (ko) 1983-04-18
FI791727A (fi) 1979-12-06
GR74057B (fr) 1984-06-06
PL116597B1 (en) 1981-06-30
NO791841L (no) 1979-12-06
ATE511T1 (de) 1982-01-15
EP0005848A1 (fr) 1979-12-12
NO149034B (no) 1983-10-24

Similar Documents

Publication Publication Date Title
AR229581A1 (es) Procedimiento para la elaboracion de derivados del alcohol 1-alpha-(n-carbamoil-hidroxi-fenoxi)-alquilen-aminometil-arilico
MX6749E (es) Procedimiento para la preparacion de derivados de tetrazolilalcoxicarboestirilo
AR222834A1 (es) Procedimiento para la preparacion de derivados de 2-nitroimidazol
AR222464A1 (es) Procedimiento para la elaboracion de derivados del acido 1-aminofenil o naftil-metanfosfonoso
AR221428A1 (es) Procedimiento para la preparacion de derivados de pirrolidinil-y de pirrolidinilmetil-benzamidas
ES479490A0 (es) Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles.
AR227527A1 (es) Procedimiento para la elaboracion de nuevos compuestos n-oxaciclilalquil-piperidil-diazoicos
IT7822011A0 (it) Procedimento di preparazione di derivati del lisergolo.
AR224784A1 (es) Procedimiento para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina
ES493107A0 (es) Procedimiento de preparacion de nuevos derivados del a-fe- nil-2-pirrolidin-metanol
MX5594E (es) Procedimiento mejorado para la preparacion de derivados de n-trifluoroacetil-n-fosfonometilglicinatos
ES499834A0 (es) Procedimiento para la obtencion de nuevos derivados del aci-do lignosulfonicos
MX5382E (es) Procedimiento para la preparacion de alcohol alfa-trifluoro-metil-3-fenoxibencilico
MX5826E (es) Procedimiento para la obtencion de derivados de fenilimino metil-piridina
ES499913A0 (es) Procedimiento para la obtencion de derivados del amino-tia- diazolilo
MX5955E (es) Procedimiento para la preparacion de derivados de piridoxina
ES488835A0 (es) Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina
IT1132528B (it) Procedimento per la preparazione di derivati del 15-idrossiimmino-e-omoeburano
MX5674E (es) Procedimiento para la preparacion de derivados de la butenofenona
MX5445E (es) Procedimiento para la preparacion de derivados de isotiocianobenzotiazol
AR231636A1 (es) Procedimiento para la elaboracion de nuevos derivados de 5-alquilo-benzimidazol-2-sustituidos
ES495153A0 (es) Procedimiento para la obtencion de derivados del decahidro- quinolinol
MX5864E (es) Procedimiento mejorado para la preparacion de derivados del 2-bromo-ergoleno y del 2-bromo-ergolino
ES491871A0 (es) Procedimiento para la obtencion de derivados de guanidina
AR221715A1 (es) Proceso para la preparacion de derivados de tiazol